Evotec SE (EVO) Current Deferred Revenue (2009 - 2026)
Evotec SE (EVO) posted Current Deferred Revenue of $9031.1 for Q1 2026, down 7.08% sequentially from $9719.8 in Q4 2025, and down 70.54% YoY from $30660.3 in Q1 2025.
Evotec SE (EVO) Current Deferred Revenue (2009 - 2026) Analysis & Trends
Evotec SE has reported Current Deferred Revenue for 9 years, with the latest figure at $9031.1 in Q1 2026.
- Quarterly Current Deferred Revenue fell 70.54% year-over-year to $9031.1 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9031.1 (down 70.54% YoY) and the FY2025 annual result came in at $9719.8, down 99.99% from the prior year.
- Current Deferred Revenue fell to $9031.1 in Q1 2026 per EVO's latest filing, from $9719.8 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $125.4 million in Q4 2022 and troughed at -$142951.5 in Q2 2022.
- A 5-year average of $28.7 million and a median of $15493.7 in 2022 frame the typical range for Current Deferred Revenue.
- The widest YoY moves for Current Deferred Revenue: up 11.48% in 2025, down 99.99% in 2025.
- Over 5 years, Current Deferred Revenue stood at $125.4 million in 2022, then declined by 16.28% to $105.0 million in 2023, then gained by 8.49% to $113.9 million in 2024, then tumbled by 99.99% to $9719.8 in 2025, then fell by 7.08% to $9031.1 in 2026.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $9031.1, $9719.8, and $10668.8 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Evotec SE | 692.56 Mn | 692.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,031.13 |
| Dec 31, 2025 | 9,719.76 |
| Sep 30, 2025 | 10,668.80 |
| Jun 30, 2025 | 31,697.14 |
| Mar 31, 2025 | 30,660.33 |
| Dec 31, 2024 | 113.91 Mn |
| Sep 30, 2024 | 9,569.88 |
| Dec 31, 2023 | 105.00 Mn |
| Dec 31, 2022 | 125.41 Mn |
| Sep 30, 2022 | 14,695.60 |
| Jun 30, 2022 | -142,951.45 |
| Mar 31, 2022 | 16,291.85 |
| Dec 31, 2021 | 128.19 Mn |
| Sep 30, 2021 | 21,181.18 |
| Dec 31, 2020 | 79.26 Mn |
| Sep 30, 2010 | 6,226.52 |
| Jun 30, 2010 | 6,318.09 |
| Mar 31, 2010 | 6.14 |
| Dec 31, 2009 | 8,096.93 |
| Jun 30, 2009 | 9.79 Mn |